Evidence map›Paper›PMID 33634026›Full record

ReviewFrontiers in oncology2020

Application of Multimodal and Molecular Imaging Techniques in the Detection of Choroidal Melanomas.

Xuying Li, Lixiang Wang, Li Zhang, Fei Tang, Xin Wei

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Diagnostic value ofAnnals of nuclear medicine · 2025
    Article
  2. Diagnostic value ofCancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Article
  3. Advances in Positron Emission Tomography/Computed Tomography for Diagnosing and Managing Primary Posterior Uveal Melanoma.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Choroidal Melanoma: A Mini Review.Medicines (Basel, Switzerland) · 2023
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Xuying LiDepartment of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China.
Lixiang WangDepartment of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China.
Li ZhangDepartment of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China.
Fei TangDepartment of Ophthalmology, ShangjinNanfu Hospital, Chengdu, China.
Xin WeiDepartment of Ophthalmology, West China Hospital, Sichuan University, Chengdu, China.
Sichuan University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Choroidal melanomas are the most common ocular malignant tumors worldwide. The onset of such tumors is insidious, such that affected patients often have no pain or obvious discomfort during early stages. Notably, enucleation is required for patients with a severe choroidal melanoma, which can seriously impact their quality of life. Moreover, choroidal melanomas metastasize early, often to the liver; this eventually causes affected patients to die of liver failure. Therefore, early diagnosis of choroidal melanomas is extremely important. Unfortunately, an early choroidal melanoma is easily confused with a choroidal nevus, which is the most common benign tumor of the eye and does not often require surgical treatment. This review discusses recent advances in the use of multimodal and molecular imaging to identify choroidal melanomas and choroidal nevi, detect early metastasis, and diagnose patients with choroidal melanomas.

Indexed as

choroidal melanomadiagnosismultimodal imagingpositron-emission tomography/computed tomography scanstaging

Identifiers

PMID33634026
PMCPMC7902045
OpenAlexW3127072082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.